Welcome to our dedicated page for Metropolitan Bank SEC filings (Ticker: MCB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing a community bank’s credit tables and CECL footnotes can take hours. Metropolitan Bank’s disclosures are no exception: hundreds of pages detail loan concentrations across New York commercial real estate, shifts in deposit composition, and evolving net-interest margins. If you have ever wondered where the allowance build sits or when executives last bought shares, this SEC filings hub removes that frustration.
How it works: Our platform ingests every Metropolitan Bank insider trading Form 4 transactions notice, each Metropolitan Bank quarterly earnings report 10-Q filing, and every Metropolitan Bank 8-K material event within minutes of EDGAR release. AI-powered summaries translate banking jargon—tier 1 capital, liquidity ratios—into plain English, turning Metropolitan Bank SEC filings explained simply into a reality. Use real-time alerts for Metropolitan Bank Form 4 insider transactions real-time or drill into the Metropolitan Bank proxy statement executive compensation numbers without wading through PDFs.
Investors use these filings to track credit quality trends, compare quarter-over-quarter loan growth, or spot Metropolitan Bank executive stock transactions Form 4 ahead of dividend announcements. Need a deeper dive? Our AI highlights section-level changes so understanding Metropolitan Bank SEC documents with AI becomes effortless. Whether you’re scanning the Metropolitan Bank annual report 10-K simplified for segment breakouts or seeking Metropolitan Bank earnings report filing analysis on net-interest income, you’ll find every document, every update, and expert context in one place.
Metropolitan Bank Holding Corp. (MCB) director George J. Wolf Jr. reported a late Form 4 disclosing a gift of 20 shares of the company's common stock on 09/15/2025. The transaction is coded G (gift) at a $0 price and was reported late due to an inadvertent administrative oversight. After the reported disposition, Mr. Wolf beneficially owns 27,715 shares directly, which includes restricted stock units that vest 100% on January 27, 2026. The form was signed by an attorney-in-fact on 09/25/2025. The filing notes Mr. Wolf's role as a director and indicates the gift was to a grandchild.
Metropolitan Bank Holding Corp. (MCB) Form 4 shows Director Robert C. Patent reported changes in his beneficial ownership on 09/18/2025. The filing discloses a disposition of 32,882 shares of common stock (transaction code J) and indicates the Reporting Person relinquished a power of attorney previously held over sibling-owned shares. The report lists 98,685 shares disposed (by sibling) and 14,445 shares held indirectly via a profit sharing plan, with restricted stock units noted to vest 100% on January 27, 2026. The signature is by an attorney-in-fact on behalf of the reporting person.
Metropolitan Bank Holding Corp. (MCB) insider sale by Executive Vice President Nick Rosenberg on 09/17/2025. Mr. Rosenberg sold a total of 1,250 shares in three blocks—161 at a weighted average of $78.1163, 339 at $78.8821, and 750 at $80.0242—under a Rule 10b5-1 trading arrangement adopted June 6, 2025. After these transactions his reported direct beneficial ownership decreased from prior levels to 28,339 shares. The filing also notes indirect holdings of 250 shares each for three children and the inclusion of restricted stock units that vest on scheduled anniversaries beginning March 1, 2024 through 2026. The Form 4 was signed by an attorney-in-fact on 09/18/2025.
Form 144 filed for Metropolitan Bank Holding Corp. (MCB) shows an insider sale program notice and a recent insider sale. The notice lists a proposed sale of 3,750 shares of common stock to be executed through J.P. Morgan Securities on September 17, 2025, with an aggregate market value of $290,475. The company has 10,421,384 shares outstanding, so the proposed sale represents approximately 0.036% of outstanding shares. The filer previously sold 1,250 shares on July 3, 2025 for gross proceeds of $93,815. Acquisition details show the shares to be sold were granted as executive compensation in multiple awards between 2018 and 2021 totaling the amounts listed in the filing. The filer certifies no undisclosed material adverse information.
Metropolitan Bank Holding Corp. insider report: Director Dale C. Fredston sold a total of 3,000 shares of the issuer on 09/03/2025 in two sets of transactions. The larger block of 2,841 shares was sold at a weighted-average price of $78.6167 (individual prices ranged $78.05–$79.042). A second block of 159 shares was sold at a weighted-average price of $79.2727 (prices ranged $79.107–$79.36). After these sales the reported beneficial ownership is shown as 14,168 shares (with a prior line showing 14,327 that includes restricted stock units). The filing discloses that restricted stock units vesting 100% on January 27, 2026 are included in the beneficial ownership figure.
Form 144 notice from an insider of Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $235,530 and an approximate sale date of 09/02/2025. The filer acquired 2,500 of the shares as a stock award on 01/24/2025 (compensation) and 500 shares by purchase in the market on 03/19/2020 for cash. There were no securities sold in the past three months by the reporting person, and the filer represents no undisclosed material adverse information. The filing is a routine insider sale notice required under Rule 144.
Robert C. Patent, a director of Metropolitan Bank Holding Corp. (MCB), reported the sale of 5,000 shares of the issuer's common stock on 08/27/2025 at a weighted average price of $79.0194. After the sale, the filing shows 98,685 shares beneficially owned directly (which includes restricted stock units that vest 100% on January 27, 2026), plus 32,882 shares held indirectly via a sibling and 14,445 indirectly via a profit sharing plan. The report includes a power of attorney disclosure regarding the sibling-held shares and notes the sale prices ranged from $78.74 to $79.2237.
Form 144 notice for Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 5,000 shares of common stock through J.P. Morgan Securities with an approximate sale date of 08/27/2025 and an aggregate market value of $395,550. The filing shows total shares outstanding of 10,421,384, and states the 5,000 shares were originally received as board compensation (4,100 shares on 12/08/2016 and 900 shares on 08/11/2018). The notice also lists recent sales by the same holder in the past three months: 5,000 shares on 07/11/2025 (gross proceeds $391,845) and two sales on 08/20/2025 totaling 5,000 shares (gross proceeds $152,891 and $210,840).
Terence J. Mitchell, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of common stock on 08/19/2025. The Form 4 shows 4,796 shares sold at a weighted average price of $72.4401, with prices in the transactions ranging from $72.1801 to $72.5800. After the sale, the reporting person beneficially owns 13,230 shares, which includes restricted stock units that vest 100% on January 27, 2026. The filing indicates the report was signed by an attorney-in-fact on 08/21/2025. All information is limited to the transactions and holdings disclosed on the Form 4.
Robert C. Patent, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of 5,000 shares of the issuer's common stock on 08/19/2025 at a weighted-average price of $72.7460 per share. After the reported transaction, the reporting person directly beneficially owns 103,685 shares.
The filing also shows indirect holdings of 32,882 shares via a sibling (over which the reporting person holds a power of attorney but disclaims beneficial ownership) and 14,445 shares held indirectly through a profit sharing plan. The report notes restricted stock units that vest 100% on January 27, 2026. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/21/2025.